GlassScriptPhysician profile
John C Hendrick
NPI 1205811957
$3,111.18
in general payments reported to CMS, 2019-2025
15 companies · $1,321 in 2025
The $1,321 reported for 2025 was more than what 93% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.04 · 2022: $635 · 2023: $584 · 2024: $506 · 2025: $1,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,410.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $695.11 | 2022-2025 | Avalus, Penditure, Mosaic |
| Abiomed | $676.91 | 2023-2025 | Impella |
| Atricure, INC. | $397.95 | 2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System |
| Terumo Cardiovascular Systems Corporation | $322.66 | 2022 | |
| Philips North America LLC | $156.13 | 2022-2025 | (Am5) Lead Management, Trillium Cushions, Lm Undivided |
| Stryker Corporation | $154.00 | 2025 | Na |
| Edwards Lifesciences Corporation | $134.63 | 2022 | |
| Silk Road Medical, INC. | $128.53 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Haemonetics Corporation | $122.79 | 2024 | Teg6s Hemostasis System |
| Boston Scientific Corporation | $103.17 | 2025 | Enroute Transcarotid Neuroprotection System |
| Merck Sharp & Dohme LLC | $102.03 | 2023 | Keytruda |
| Getinge USA Sales, LLC | $66.04 | 2021 | |
| Janssen Biotech, INC. | $20.32 | 2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $17.45 | 2024 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $13.46 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hendrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.